HDAC inhibitors have been examined extensively in ALS models (SOD1G93A mice, FUS and C9ORF72 mice models (detailed further in the "Therapeutic interventions for ageing and ageing-related diseases" section) [85, 101]. The gene discussed is HDAC9; the disease is amyotrophic lateral sclerosis.